Novo Nordisk has made its smart ... The new devices – NovoPen 6 and NovoPen Echo Plus – are insulin self-injection pens that record information such as when and how much insulin is ...

Danish drugmaker Novo Nordisk on Wednesday posted another quarter of rapid profit growth, though the story for once wasn’t ...

Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...

It has been estimated that 90% of medical device waste consists of single-use products or components, so a new initiative by Novo Nordisk to recycle pre-filled injection pens used by people living ...

That haul helped Novo’s total sales for 2024 grow 26% at constant currencies to 290.4 billion kroner ... Holdings’ $16.5 billion Catalent acquisition in December, Novo Nordisk has purchased ...

Novo Nordisk Q4 sales ... 19.87 billion Danish kroner. Insulin sales increased 36% to 15.9 billion Danish kroner, and Rare disease sales increased 25% at CER to 5.71 billion Danish kroner.

Novo Nordisk (NVO) reported better-than-expected ... Shares of the Danish drugmaker rose ~4% in European trading, while Eli Lilly (LLY), its main rival in the obesity market, added ~2% in the ...

BAGSVAERD, Denmark (AP) — BAGSVAERD, Denmark (AP) — Novo Nordisk A/S (NVO) on Wednesday reported fourth-quarter earnings of $4.04 billion. The Bagsvaerd, Denmark-based company said it had net ...